The deal will strengthen Stryker’s portfolio of smart technologies in its joint replacement business and provide products that help physicians make data-driven decisions.
Companies developing technologies that integrate AI need to consider regulatory concerns, community demographics, fitting into existing workflows, technical proficiency of both the hospital personnel and consumers.
Although the medtech industry is expected to enjoy steady growth, device companies are still challenged to attract the skilled labor that manufacturing requires.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
Across the continent, governments and hospitals are purchasing robotics systems from abroad as well as developing the technologies themselves.
Despite pricing pressures, several sectors within the medical device industry can expect to enjoy growth and attract attention from investors.
The deal will help J&J speed up its entry into the robotics market.
Several technologies that can streamline procedures for surgeons in the OR are in development.